Early trial halted for advanced liver cancer cell therapy
NCT ID NCT04502082
Summary
This early-stage trial tested a new treatment for advanced liver cancer. Doctors took a patient's own immune cells, modified them in a lab to better target cancer, and then put them back into the patient. The main goal was to find a safe dose, but the study was stopped early by the company to focus on a similar trial in children.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
-
Kansas University Medical Center
Westwood, Kansas, 66205, United States
Conditions
Explore the condition pages connected to this study.